If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. If you’re dealing with a respiratory illness, it can be ...

A nebulizer is a special device that warms or otherwise changes a liquid solution into a fine mist that’s easy to inhale. Some people call nebulizers breathing machines. Nebulizers are useful in ...

Which portable nebulizer is best? For anyone who has chronic issues with breathing, a nebulizer can be a game-changer. It lets you live a whole, rich life you may not have believed possible. That’s ...

To be effective in treating respiratory illnesses, liquid drugs must be utilized in an aerosol with an effective and defined drop size distribution for inhaled medications. To meet these intense ...

- LONHALA MAGNAIR is the first nebulized long-acting muscarinic antagonist (LAMA) available for the treatment of COPD in the U.S. - MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc.

Lonhala Magnair is available as a 25mcg strength inhalation solution per 1mL vial. Sunovion announced the launch of Lonhala Magnair (glycopyrrolate) inhalation solution for the long-term, maintenance ...

An Islip doctor who helped author a state law that led to greater availability of nebulizers to treat asthma in schools said he is concerned that new federal guidelines, favoring specially adapted ...

The first DTC ad campaign for Viatris and Theravance’s COPD nebulizer therapy Yupelri aims to show the freedom of the once-daily treatment. In a newly debuted TV ad, an older woman celebrates her ...

U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa - First ...

Autoimmune PAP is a rare lung disease characterized by the abnormal build-up of surfactant in the alveoli of the lungs. Surfactant consists of proteins and lipids and is an important physiological ...

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, reports that the Israeli Patent Office (ILPO) ...